Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Interest Expenses (2016 - 2025)

Historic Interest Expenses for AC Immune (ACIU) over the last 11 years, with Q3 2025 value amounting to -$57503.4.

  • AC Immune's Interest Expenses fell 5097.18% to -$57503.4 in Q3 2025 from the same period last year, while for Sep 2025 it was -$329313.7, marking a year-over-year increase of 3218.07%. This contributed to the annual value of -$151822.4 for FY2024, which is 2348.22% up from last year.
  • AC Immune's Interest Expenses amounted to -$57503.4 in Q3 2025, which was down 5097.18% from -$60394.5 recorded in Q2 2025.
  • In the past 5 years, AC Immune's Interest Expenses ranged from a high of $163504.1 in Q1 2022 and a low of -$624673.2 during Q4 2021
  • Moreover, its 5-year median value for Interest Expenses was -$57503.4 (2025), whereas its average is -$108988.4.
  • Per our database at Business Quant, AC Immune's Interest Expenses surged by 749129.15% in 2022 and then plummeted by 3561418.13% in 2023.
  • AC Immune's Interest Expenses (Quarter) stood at -$624673.2 in 2021, then soared by 100.17% to $1038.0 in 2022, then tumbled by 35614.18% to -$368644.9 in 2023, then grew by 28.47% to -$263691.6 in 2024, then soared by 78.19% to -$57503.4 in 2025.
  • Its Interest Expenses was -$57503.4 in Q3 2025, compared to -$60394.5 in Q2 2025 and $52275.8 in Q1 2025.